Financial News with AI Impact Scores

Invivyd shares are trading higher after BTIG initiated coverage on the stock with a Buy rating and announced a $10 price target.

Cytokinetics shares are trading higher after the company announced that the FDA approved MYQORZO, 5 mg, 10 mg, 15 mg, 20 mg tablets for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy to improve functional capacity and symptoms.

Polestar Automotive shares are trading higher after the company announced a $300 million equity investment from Banco Bilbao Vizcaya Argentaria and Natixis.

Rocket Lab Mach 70: Why The Stock Is At All-Time Highs

Rocket Lab Corp. (NASDAQ: RKLB) has reached an all-time high stock price of $78.21, reflecting significant growth following the acquisition of an $816 million contract with the U.S. Space Development Agency. The company completed a flawless 2025 with 21 launches and a 100% mission success rate, establishing itself as a reliable player in the aerospace sector. With a backlog exceeding $1 billion and a shift towards vertical integration in defense contracting, Rocket Lab is positioning itself as a key competitor in the space industry.

Blue Gold shares are trading higher after the company announced a strategic LOI with Trust Stamp to develop a biometrically secured, passwordless "Wallet-of-Wallets" platform for Gold-Backed Digital Assets.

Jones Trading Initiates Coverage On Whitehawk Therapeutics with Buy Rating, Announces Price Target of $7

Jones Trading analyst Soumit Roy has initiated coverage on Whitehawk Therapeutics (NASDAQ: WHWK) with a Buy rating. The firm has set a price target of $7 for the stock.

B. Riley Securities Maintains Buy on Kymera Therapeutics, Raises Price Target to $117

B. Riley Securities analyst Kalpit Patel has maintained a Buy rating on Kymera Therapeutics (NASDAQ: KYMR) and increased the price target from $80 to $117. This adjustment reflects a positive outlook for the company's performance.

Cosmos Health shares are trading higher after a Form 4 filing showed its CEO purchased 88,314 shares at an average price of $0.49.

B. Riley Securities Maintains Buy on Intuitive Machines, Raises Price Target to $20

B. Riley Securities analyst Mike Crawford has maintained a 'Buy' rating on Intuitive Machines (NASDAQ: LUNR) and raised the price target from $14 to $20. This adjustment reflects a positive outlook for the company's stock performance.

HYPERION DEFI shares are trading higher after a Form 4 filing showed a director purchased 38,444 shares at an average price of $3.14.